Amylin Pharmaceuticals Inc. (AMLN)

[WID]

Musings on Amylin-inVentiv Deal

I revisited the Amylin-inVentiv Deal and thought that it might imply something:

Why AMLN does not create a sale force for Bydureon if the company want to make big $$$ on this blockbuster drug?

Why AMLN said in the agreement that it can notify inVentiv 60 days in advance to terminate the deal if necessary?

The deal at the time when the drug received FDA approval tell me that AMLN wants to sell the company to a big pharma that may have a well established diabetes sale force; thus AMLN does not have to layoff new hires for Bydureon commercial.

I think that AMLN will be taken over in the next 12 to 24 months.

What do you think?

All the best!
WID